We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
John Groarke MBBCh, MSc, MPH

John D Groarke MBBCh, MSc, MPH

Cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH), Cardio-oncologist at Dana Farber Cancer Institute, Instructor of medicine at Harvard Medical School (HMS), Boston, MA

Having graduated with honors and academic awards from medical school at Trinity College Dublin, Ireland, Dr. Groarke completed internal medicine residency and general cardiology fellowship, receiving a Certificate of Completion of Specialist Training from the Royal College of Physicians of Ireland. He then completed clinical fellowships in advanced cardiovascular imaging, cardio-oncology, and advanced heart failure/mechanical circulatory support/heart transplantation at Brigham & Women’s Hospital, Boston between 2011 and 2015. In July 2015, he was appointed as an associate physician with the Division of Cardiovascular Medicine, BWH and Cardio-Oncology Program at Dana Farber Cancer Institute, and as an Instructor of Medicine at Harvard Medical School. In this role, he offers subspecialty expertise in advanced heart failure, mechanical circulatory support, heart transplantation, cardio-oncology, and cardiopulmonary exercise testing.

Dr. Groarke has completed a Masters in Science through Trinity College Dublin, and a Masters in Public Health through Harvard School of Public Health. He represents Harvard University on a national expert clinical research committee called the Heart Failure Apprentice Network (HFAN) – a clinical research initiative funded by the National Heart Lung and Blood Institute. His primary clinical research focus is in the field of cardio-oncology, a dynamic and evolving cardiology subspecialty committed to improving the cardiovascular wellbeing of the growing population of cancer survivors. He has secured institutional and industry funding to develop cardio-oncology clinical research across BWH and DFCI. He has made meaningful contributions to cardio-oncology clinical research literature, and is regularly invited to speak at national and international conferences as testimony to his emergence as a thought-leader in this field.


Dr. Groarke reports no disclosures.